SALVATORE, Giuliana
 Distribuzione geografica
Continente #
NA - Nord America 5.995
EU - Europa 2.106
AS - Asia 586
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 4
AF - Africa 2
SA - Sud America 2
Totale 8.714
Nazione #
US - Stati Uniti d'America 5.990
UA - Ucraina 669
VN - Vietnam 377
SE - Svezia 342
IT - Italia 291
GB - Regno Unito 282
DE - Germania 196
CN - Cina 191
FR - Francia 128
NL - Olanda 70
FI - Finlandia 65
EU - Europa 19
BE - Belgio 15
PL - Polonia 15
IE - Irlanda 10
CA - Canada 5
KR - Corea 4
AT - Austria 3
JP - Giappone 3
PT - Portogallo 3
RO - Romania 3
RU - Federazione Russa 3
TR - Turchia 3
AU - Australia 2
BG - Bulgaria 2
IL - Israele 2
IN - India 2
NZ - Nuova Zelanda 2
RS - Serbia 2
BT - Bhutan 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
PY - Paraguay 1
SG - Singapore 1
VE - Venezuela 1
Totale 8.714
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Seattle 395
Ashburn 393
Dong Ket 377
Wilmington 377
Cambridge 327
Nyköping 220
Dearborn 207
Jacksonville 177
Southend 146
Napoli 76
Beijing 72
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Boardman 53
Ogden 52
New York 47
San Diego 36
Naples 32
Des Moines 24
Formia 23
Jinan 17
Milan 17
Norwalk 17
London 16
Brussels 14
Hefei 14
Kunming 13
Los Angeles 13
Boydton 12
Helsinki 12
Auburn Hills 11
Kraków 11
Nanjing 10
Düsseldorf 9
Redmond 9
Afragola 8
Bremen 8
Dublin 8
Edinburgh 8
Nocera Inferiore 8
Redwood City 8
Rome 6
Shenyang 6
Atlanta 5
Guangzhou 5
Kilburn 5
Nanchang 5
Nocera Superiore 5
St Louis 5
Hangzhou 4
Matawan 4
Zhengzhou 4
Altavilla Irpina 3
Casoria 3
Chongqing 3
Costa Mesa 3
Fuzhou 3
Kocaeli 3
Lisbon 3
Pescara 3
Stockholm 3
Tokyo 3
Vienna 3
Wandsworth 3
Warsaw 3
Wuhan 3
Acton 2
Agropoli 2
Amsterdam 2
Assisi 2
Baotou 2
Belgrade 2
Castellammare Di Stabia 2
Changsha 2
Chengdu 2
Chiswick 2
Como 2
Frankfurt am Main 2
Giugliano in Campania 2
Haikou 2
Hanover 2
Islington 2
Lanzhou 2
Leawood 2
Ottawa 2
Pisticci 2
Prato 2
Priverno 2
Salerno 2
San Mateo 2
Sant'anastasia 2
Sofia 2
Tianjin 2
Totale 6.840
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 279
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 235
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 199
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 194
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 193
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 191
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 189
Long-term recreational football training and health in aging 188
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 181
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 174
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 170
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 166
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 164
BAY 43-9006 inhibition of oncogenic RET mutants. 154
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 154
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 152
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 152
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 150
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 149
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 147
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 147
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 145
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 144
Identification of targets of twist1 transcription factor in thyroid cancer cells. 143
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 141
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 140
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 138
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 137
Receptor tyrosine kinase inhibitors in thyroid cancer 136
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 134
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 134
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 132
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 132
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 131
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 129
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 128
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 128
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 127
Different mutations of the RET gene cause different human tumoral diseases 125
Morphological ultrasound microimaging of thyroid in living mice 125
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 124
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 124
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 121
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 117
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 116
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 115
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 113
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 111
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 110
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 109
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 108
Molecular biology of the MEN2 gene 107
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 106
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 105
Pros and cons of cellular studies in developing new drugs for thyroid cancers 104
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 102
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 96
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 96
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 83
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 80
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 78
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 66
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 65
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 60
Regular football training down-regulates miR-1303 muscle expression in veterans 55
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 54
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 41
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 32
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 30
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 10
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 5
Totale 8.920
Categoria #
all - tutte 30.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019415 0 0 0 0 0 0 0 0 0 92 175 148
2019/20202.602 179 181 174 533 302 276 324 210 207 58 115 43
2020/20211.740 104 140 173 123 147 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024309 29 29 34 23 11 48 19 14 79 23 0 0
Totale 8.920